Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014.
September 14, 2022 at 04:23 pm EDT
Share
From May 1, 2022 to July 31, 2022, the company has repurchased 10,400 shares, for $0.00936 million. With this, the company has completed the repurchase of 448,057 shares, for $0.44 million under the buyback announced on June 16, 2014.
Pharma-Bio Serv, Inc. is a compliance and technology transfer services consulting company. The Company operates through four segments: Puerto Rico technical compliance consulting, United States technical compliance consulting, Europe technical compliance consulting, and Puerto Rico microbiological and chemical laboratory testing division (Lab). The Company provides a range of compliance-related consulting services. The Company provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. The Company's technical consulting services include regulatory compliance, validation, technology transfer, engineering, project management and process support. The Company markets its services to pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies in Puerto Rico, the United States, Europe and Brazil.
PHARMA-BIO SERV, INC. 
